MedTrace Logo

Ketamine and Refractory Painful Care in a Palliative Unit

NCT02587130 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2020-03-03

No results posted yet for this study

Summary

Pain is one of the major symptoms in palliative care units and often is very difficult to treat, being considered as a refractory pain.

There are different causes of refractory pain: pain due to bed sores and ulcer bandages, carcinological or ischemic wounds or injuries, pain due to patients' reduced mobility, pain due to traumatological injuries, pain associated with a long-term bed confinement, etc.

The investigators propose a prospective study to estimate the effect and the tolerance to a subcutaneous bolus of ketamine administered for the treatment of refractory pain due to the care of bedsores, ulcers and vascular wounds in patients hospitalized in palliative care units.

Conditions

  • Intractable Pain
  • Intensive Care
  • Pressure Ulcer
  • Pain Management

Interventions

DRUG

Ketamine

ketamine administered in bolus by subcutaneous injection

Sponsors & Collaborators

  • Lille Catholic University

    lead OTHER

Principal Investigators

  • Marie Danel Delerue, MD · Groupment des Hôpitaux de l'Institut Catholique de Lille

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-31
Primary Completion
2019-01-10
Completion
2019-01-10

Countries

  • France

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02587130 on ClinicalTrials.gov